China SXT Pharmaceuticals Inc (SXTC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
3,396,000
EV to revenue ratio (TTM)
43.06
EV to ebitda
7.08
Financial Performance
Revenue (TTM)
1,138,100
Gross profit (TTM)
248,700
EBITDA
-7,049,265
Profitability
Operating margin (TTM)
-153.30%
Profit margin
0.00%
Return on assets (TTM)
-15.80%
Return on equity (TTM)
-27.50%
Per Share Metrics
Revenue per share (TTM)
1.67
EPS
-730.4
Diluted EPS (TTM)
-730.4
Book value
2,480.58
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
2.984
Price to book ratio (TTM)
0.112
Growth
Quarterly earnings growth (YoY)
-43.90%
Quarterly revenue growth (YoY)
42.60%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
1.842